Clinical Trial Management Statistics

Clinical Trial Management Statistics 2023: Facts about Clinical Trial Management outlines the context of what’s happening in the tech world.

LLCBuddy editorial team did hours of research, collected all important statistics on Clinical Trial Management, and shared those on this page. Our editorial team proofread these to make the data as accurate as possible. We believe you don’t need to check any other resources on the web for the same. You should get everything here only 🙂

Are you planning to form an LLC? Maybe for educational purposes, business research, or personal curiosity, whatever the reason is – it’s always a good idea to gather more information about tech topics like this.

How much of an impact will Clinical Trial Management Statistics have on your day-to-day? or the day-to-day of your LLC Business? How much does it matter directly or indirectly? You should get answers to all your questions here.

Please read the page carefully and don’t miss any words.

Top Clinical Trial Management Statistics 2023

☰ Use “CTRL+F” to quickly find statistics. There are total 10 Clinical Trial Management Statistics on this page 🙂

---

Clinical Trial Management “Latest” Statistics

• Approximately 40% of clinical trials are supported by noncommercial sponsors, mostly academics, and the pharmaceutical sector funds 60%.^[1]
• 97% of those that responded and used new techniques for clinical trials during the pandemic said their organization would continue to use at least one of these new techniques.^[2]
• 58% of respondents, a small majority, said that their organizations intend to provide patients with the choice of how they participate in clinical studies.^[2]
• The COVID-19 pandemic, according to 76% of respondents in an industry poll conducted by Informa Pharma Intelligence and Oracle last year, has increased the use of decentralized clinical trial approaches.^[2]
• Most survey participants anticipate a rise in fit-for-purpose, hybrid, and/or decentralized clinical trial models in the future, 63% of whom expect these models to be utilized for both new studies and the restarts of current trials.^[2]
• Survey participants who used novel clinical trial techniques during the pandemic anticipated their organizations would utilize hybrid models more often (44%) and fit-for-purpose models more frequently (42%).^[2]

Clinical Trial Management “Other” Statistics

• The compliance rate increased between April 2019 and June 2022 from 24% to 64% for noncommercial sponsors to 77% to 86% for commercial sponsors.^[1]
• Among the four models: evaluated, site-based, fit-for-purpose, hybrid, and decentralized models, respondents expect a 24% drop in site usage.^[2]
• A whopping 87% of survey participants reported being able to utilize most or all of the extra data their recently deployed procedures have produced.^[2]
• 76% of responses were from biopharmaceutical businesses, while the remaining respondents were from medical device companies and CROs.^[2]

Also Read

How Useful is Clinical Trial Management

One of the key benefits of clinical trial management is its ability to provide high-quality, reliable data. By following well-defined protocols and procedures, researchers can collect accurate and consistent data that can be used to determine the safety and efficacy of a new treatment. This data is essential for regulatory agencies like the Food and Drug Administration (FDA) to evaluate whether a new drug or treatment should be approved for use in the general population.

Another important aspect of clinical trial management is patient safety. Researchers must ensure that participants are treated ethically and that their rights and well-being are protected throughout the trial. This includes obtaining informed consent, monitoring participants for any adverse events, and ensuring that the trial is conducted in accordance with ethical guidelines and regulatory requirements.

In addition to ensuring the safety and effectiveness of new treatments, clinical trial management also plays a crucial role in advancing medical knowledge. By conducting clinical trials, researchers can generate valuable data that can be used to improve existing treatments, develop new therapies, and better understand the mechanisms of disease. This knowledge can ultimately lead to better patient outcomes and improved healthcare practices.

Furthermore, clinical trial management can also have economic benefits. By demonstrating the safety and effectiveness of a new treatment through clinical trials, pharmaceutical companies can gain approval to bring their product to market. This can result in significant financial gains for the company, as well as increased access to new treatments for patients who may benefit from them.

In conclusion, clinical trial management is a critical component of the healthcare and pharmaceutical industries. It provides high-quality data that is essential for evaluating the safety and efficacy of new treatments, protects the rights and well-being of participants, advances medical knowledge, and can have economic benefits for pharmaceutical companies. Through effective clinical trial management, researchers can ensure that new treatments are safe, effective, and ultimately improve patient outcomes.

Reference

---

1. europa – https://www.ema.europa.eu/en/human-regulatory/research-development/clinical-trials-human-medicines
2. oracle – https://www.oracle.com/industries/life-sciences/clinical-research/clinical-trials-post-covid-research/